Nov 272017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, NJ – Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the appointment of renowned biotech entrepreneur Thomas F.=> Read more

Cancer Genetics welcomes Dr Thomas Widmann to its Board of Directors

From:: Cancer Genetics welcomes Dr Thomas Widmann to its Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: